HealthAug 14, 2026
Khartis raises $95.0M (Aug 2026)
$95.0M
USD 95mGenerated social card
Headline
Khartis bags USD 95m for oral challenger to Tepezza - AllSci
About
Khartis is a biopharmaceutical company focused on developing innovative oral therapies. The company aims to provide effective alternatives to existing treatments, specifically targeting conditions treated by Tepezza. This funding round will support their efforts in advancing their oral challenger to Tepezza.
Article summary
Khartis bags USD 95m for oral challenger to Tepezza AllSci
Investors
Related rounds
| Aug 14, 2026 | InduPro | $77.0M | Series B | United States |
| Aug 13, 2026 | Wondermind | $1.2M | — | — |
| Aug 13, 2026 | Whoop | $575.0M | Series G | United States |
| Aug 13, 2026 | Aligned Marketplace | $20.0M | — | United States |